Business Wire
BusinessAMD and Cisco link up on AI infrastructure in Saudi Arabia, lifting shares as details remain thinThe Apex TimesBusinessAdobe’s “$4 billion Saudi AI giveaway” spooks headlines, but investors shruggedThe Apex TimesBusinessBaird points to accelerating enterprise AI adoption as reason for bullish view on PalantirThe Apex TimesBusinessOracle’s Contracted Backlog Surpasses $600 Billion, Highlighting the Gap Between Promised Revenue and Market ValueThe Apex TimesBusinessExxon Mobil rises about 2% as oil rebounds, but misses a key Washington gas-price forumThe Apex TimesBusinessEnergy stocks lift as oil prices rise again, pulling Exxon Mobil and peers higherThe Apex TimesBusinessTim Cook’s Goodbye Note to Apple Staff Marks a 15-Year Run at the TopThe Apex TimesBusinessTesla’s revenue growth is narrowing the gap with General Motors, chart suggestsThe Apex TimesBusinessBank of America points to a shift in how gold is being positioned, Yahoo Finance reportsThe Apex TimesBusinessMeta and Alphabet’s exposure to Jio Platforms faces a valuation test as India’s IPO hype buildsThe Apex TimesBusinessCathie Wood’s Ark cuts AMD in a $124 million shift within its AI stock basket, Yahoo Finance reportsThe Apex TimesBusinessEli Lilly to buy Merida Biosciences for $2.88 billion, setting off investor focus on the deal’s strategic fitThe Apex TimesBusinessAMD and Cisco link up on AI infrastructure in Saudi Arabia, lifting shares as details remain thinThe Apex TimesBusinessAdobe’s “$4 billion Saudi AI giveaway” spooks headlines, but investors shruggedThe Apex TimesBusinessBaird points to accelerating enterprise AI adoption as reason for bullish view on PalantirThe Apex TimesBusinessOracle’s Contracted Backlog Surpasses $600 Billion, Highlighting the Gap Between Promised Revenue and Market ValueThe Apex TimesBusinessExxon Mobil rises about 2% as oil rebounds, but misses a key Washington gas-price forumThe Apex TimesBusinessEnergy stocks lift as oil prices rise again, pulling Exxon Mobil and peers higherThe Apex TimesBusinessTim Cook’s Goodbye Note to Apple Staff Marks a 15-Year Run at the TopThe Apex TimesBusinessTesla’s revenue growth is narrowing the gap with General Motors, chart suggestsThe Apex TimesBusinessBank of America points to a shift in how gold is being positioned, Yahoo Finance reportsThe Apex TimesBusinessMeta and Alphabet’s exposure to Jio Platforms faces a valuation test as India’s IPO hype buildsThe Apex TimesBusinessCathie Wood’s Ark cuts AMD in a $124 million shift within its AI stock basket, Yahoo Finance reportsThe Apex TimesBusinessEli Lilly to buy Merida Biosciences for $2.88 billion, setting off investor focus on the deal’s strategic fitThe Apex TimesBusinessAMD and Cisco link up on AI infrastructure in Saudi Arabia, lifting shares as details remain thinThe Apex TimesBusinessAdobe’s “$4 billion Saudi AI giveaway” spooks headlines, but investors shruggedThe Apex TimesBusinessBaird points to accelerating enterprise AI adoption as reason for bullish view on PalantirThe Apex TimesBusinessOracle’s Contracted Backlog Surpasses $600 Billion, Highlighting the Gap Between Promised Revenue and Market ValueThe Apex TimesBusinessExxon Mobil rises about 2% as oil rebounds, but misses a key Washington gas-price forumThe Apex TimesBusinessEnergy stocks lift as oil prices rise again, pulling Exxon Mobil and peers higherThe Apex TimesBusinessTim Cook’s Goodbye Note to Apple Staff Marks a 15-Year Run at the TopThe Apex TimesBusinessTesla’s revenue growth is narrowing the gap with General Motors, chart suggestsThe Apex TimesBusinessBank of America points to a shift in how gold is being positioned, Yahoo Finance reportsThe Apex TimesBusinessMeta and Alphabet’s exposure to Jio Platforms faces a valuation test as India’s IPO hype buildsThe Apex TimesBusinessCathie Wood’s Ark cuts AMD in a $124 million shift within its AI stock basket, Yahoo Finance reportsThe Apex TimesBusinessEli Lilly to buy Merida Biosciences for $2.88 billion, setting off investor focus on the deal’s strategic fitThe Apex TimesBusinessAMD and Cisco link up on AI infrastructure in Saudi Arabia, lifting shares as details remain thinThe Apex TimesBusinessAdobe’s “$4 billion Saudi AI giveaway” spooks headlines, but investors shruggedThe Apex TimesBusinessBaird points to accelerating enterprise AI adoption as reason for bullish view on PalantirThe Apex TimesBusinessOracle’s Contracted Backlog Surpasses $600 Billion, Highlighting the Gap Between Promised Revenue and Market ValueThe Apex TimesBusinessExxon Mobil rises about 2% as oil rebounds, but misses a key Washington gas-price forumThe Apex TimesBusinessEnergy stocks lift as oil prices rise again, pulling Exxon Mobil and peers higherThe Apex TimesBusinessTim Cook’s Goodbye Note to Apple Staff Marks a 15-Year Run at the TopThe Apex TimesBusinessTesla’s revenue growth is narrowing the gap with General Motors, chart suggestsThe Apex TimesBusinessBank of America points to a shift in how gold is being positioned, Yahoo Finance reportsThe Apex TimesBusinessMeta and Alphabet’s exposure to Jio Platforms faces a valuation test as India’s IPO hype buildsThe Apex TimesBusinessCathie Wood’s Ark cuts AMD in a $124 million shift within its AI stock basket, Yahoo Finance reportsThe Apex TimesBusinessEli Lilly to buy Merida Biosciences for $2.88 billion, setting off investor focus on the deal’s strategic fitThe Apex Times
Back to front
Kala Therapy’s recovery brand, founded on a $5,000 bet, is finding a retail route through Costco
The Apex Times

THE APEX TIMES

Business/The Apex Times/Jun 18, 2:22 PM EDT

Kala Therapy’s recovery brand, founded on a $5,000 bet, is finding a retail route through Costco

Cam Stajer started a recovery-technology company at 23 with $5,000, and the brand Kala Therapy says it now supplies athletes at the highest levels and is sold through Costco.

A Canadian entrepreneur’s bet on “recovery tech” has turned into a retail brand carried by Costco, according to a business feature published by Entrepreneur. The story centers on Cam Stajer, who began developing what became Kala Therapy at age 23 with an initial investment of $5,000, after deciding that athletes needed better ways to recover between games and training.

As Kala Therapy grew, the company positioned its product as a recovery solution used by professional athletes, including NHL players and Olympians. The Entrepreneur write-up frames the pitch around recovery as a performance input, not simply after-the-fact care, and it credits Stajer’s brand-building for translating that idea into consumer product form.

The feature also says Kala Therapy’s products are now being sold through Costco, bringing the brand into a large-format retail channel known for stocking private and third-party products in volume. For a young athletic performance brand, getting onto a national retailer’s shelves is a meaningful distribution step because it can shift demand generation away from niche specialty buyers and toward mainstream shoppers who shop the club format.

Costco’s scale is often a key reason smaller brands pursue it. When companies get added to Costco assortment, it can change how quickly awareness spreads and how predictably inventory moves, because Costco’s purchasing model is tied to planned replenishment rather than one-off demand spikes.

Beyond the retailer relationship, the core business question for Kala Therapy is whether its recovery proposition is durable as a consumer category. The Entrepreneur feature highlights elite athlete usage as a announcement to customers, but it does not provide in the published write-up any details about clinical evidence, pricing, unit economics, or how the brand’s athlete marketing converts into repeat purchases.

It also remains unclear from the feature how extensive Kala Therapy’s Costco presence is. The post does not specify which Costco regions carry the products, what SKUs are included, how long the relationship has been in place, or whether Costco is the primary distribution partner or one of several channels.

In that context, the biggest near-term story for retail watchers is not just that the brand is on shelves, but what happens after the initial rollout. If shoppers re-order, if Costco expands the SKU set, and if the brand can maintain margins while supporting athlete-led marketing, recovery equipment could become a recurring line item rather than a one-time trial.

For now, the Entrepreneur feature provides a narrative of origin and adoption, but not the operational data behind it. Readers looking for specifics on sales performance, customer acquisition costs, manufacturing capacity, and product performance metrics will need additional disclosures from the company or from retail partners, which are not included in the published write-up.

Why It Matters

  • Distribution via Costco can materially broaden the customer base for sports and wellness brands, particularly those that rely on athlete credibility.
  • If the category translates from elite usage to consumer repeat purchases, recovery technology could become a sustained retail segment rather than a niche offering.
  • The story illustrates a path from small initial capital to brand-building and retail placement, which can inform how other sports performance startups think about scale.
  • Because the feature does not disclose contract terms or performance metrics, investors and analysts will need more evidence to assess the impact on margins and growth.

Sources

Key Facts

  • The Entrepreneur feature says Cam Stajer launched Kala Therapy at age 23 after starting with $5,000.
  • The company markets its products as recovery technology for athletes.
  • The feature says Kala Therapy supplies professional athletes, including NHL players and Olympians.
  • The Entrepreneur write-up says Kala Therapy products are sold at Costco.
  • No additional operational or financial details were provided in the feature about sales, contracts, or rollout scope.

Retail & Consumer Related

Aug 31, 2:06 PM EDT
The Apex Times

Walmart climbs as oil at $90 bolsters the “defensive” appeal of retailers

Investors are treating cheaper-to-own retail as a buffer again, after a sharp move in crude oil toward $90. The shift could help Walmart capture shoppers “trading down,” but higher fuel and inventory costs also pose a risk to the cash profits that support its valuation.

Walmart climbs as oil at $90 bolsters the “defensive” appeal of retailers
The Apex Times
Kala Therapy’s recovery brand, founded on a $5,000 bet, is finding a retail route through Costco | The Apex Times